When using observational or lower level interventional data, the ASIPP grading requires several studies in order to provide a rating
These can include temporary swelling, bruising, redness or tenderness in the treated areas
Any discomfort is brief and typically fades within moments
BPC-157 is described in the literature as a stable gastric pentadecapeptide, and reviews discuss its preclinical activity in gastrointestinal injury, cytoprotection, intestinal anastomosis, fistula, and inflammatory injury models (Multifunctionality and Possible Medical Application of the BPC 157 Peptide, Gastroenterology Research and Practice)
Theyre more likely to cause discomfort, inflammation, or even pain during or after the injection, which can make regular dosing unpleasant and less sustainable